News

High Dividend Yield Stocks to Consider for Your Portfolio

High Dividend Yield Stocks to Consider for Your Portfolio

Exploring Financial Stocks with Attractive Dividend Yields

Investors often seek stability and income during turbulent market conditions. High dividend-yielding stocks draw attention, as they typically belong to companies with robust cash flow, rewarding shareholders generously. In the financial sector, several companies stand out, offering attractive yields above 11%. Let's dive into these investment opportunities.

Ready Capital Corporation (NASDAQ: RC)

Ready Capital Corporation has garnered interest among income-focused investors due to its impressive dividend yield of 11.71%. Analysts hold a mix of perspectives regarding this stock.

Analyst Ratings and Insights

Analyst Jade Rahmani from Keefe, Bruyette & Woods maintains an Underperform rating on the stock, recently adjusting the price target from $4.25 to $3.75. This analyst has demonstrated an accuracy rate of 72%. Similarly, Randy Binner from B. Riley Securities has also cut his price target from $6 to $4 while maintaining a Neutral rating, reflecting an accuracy rate of 72%.

Recent Developments

On August 7, the company reported weaker-than-expected quarterly results, prompting analysts to reassess their positions. As investors look ahead, monitoring the company's ability to strengthen its financial position will be essential.

Ellington Financial Inc. (NASDAQ: EFC)

Another noteworthy player is Ellington Financial, featuring a dividend yield of 11.49%. This company's recent performance reports an upward trend in earnings, making it a more attractive option for dividend-seeking investors.

Analyst Evaluations

Analyst Douglas Harter of UBS has set a Neutral rating while slightly increasing the price target from $12 to $12.50. Harter has an accuracy rating of 69%. Additionally, Bose George from Keefe, Bruyette & Woods maintains an Outperform rating, raising the price target from $13.75 to $14.50, reflecting a solid 71% accuracy.

Current News Highlights

On August 7, Ellington Financial posted upbeat quarterly earnings, signaling strong management and operational effectiveness. This development may further enhance investor confidence moving forward.

New York Mortgage Trust, Inc. (NASDAQ: NYMT)

Completing our list is New York Mortgage Trust, which offers an attractive dividend yield of 11.25%. This stock is capturing attention as the company continues to navigate a complex financial environment.

Analyst Perspectives

Analyst Douglas Harter from UBS provided a Neutral rating while adjusting his price target from $6.50 to $6.75, maintaining an accuracy rate of 69%. Randy Binner from B. Riley Securities assigns a Buy rating and has uplifted his price target from $8 to $9, boasting a 72% accuracy rate.

Market Updates

On July 30, the company reported downbeat quarterly results, which may influence investor sentiment in the short term. Monitoring the company's strategies and adaptations to market changes will be essential for future evaluations.

Conclusion

Investors seeking strong dividend yields can find notable options in Ready Capital Corporation, Ellington Financial, and New York Mortgage Trust. Each company offers unique opportunities as well as risks, making thorough research vital before making investment decisions.

Frequently Asked Questions

What are the dividend yields for these companies?

Ready Capital Corporation yields 11.71%, Ellington Financial yields 11.49%, and New York Mortgage Trust offers 11.25%.

Which analysts cover these stocks?

These stocks are analyzed by various firms, including Keefe, Bruyette & Woods and UBS.

How can I stay updated on these stocks?

Investors can watch financial news sources and real-time news feeds for updates on these stocks.

What should I consider before investing in high dividend stocks?

Investors should evaluate the company’s financial health, dividend sustainability, and market conditions before investing.

Are dividends guaranteed?

No, dividends are not guaranteed and can be adjusted or eliminated by the company's board of directors based on financial performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Mako Hiraizumi Shines with Silver at Japan Triathlon

Updated Category News Views 115

A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...

Continue Reading
Paratus Energy Lands Petrobras Tender, Ties Finalizing

Updated Category News Views 25

Seagems Joint Venture Snags Petrobras Contract Let’s dive headfirst into this business update, because this one's got teeth, folks. Petrobras, the big dog in Brazil’s oil arena, has given the green light to Seagems’ bid, a joint venture half-owned by Paratus Energy Services Ltd. The target? A hefty pipe-laying support vessel (PLSV) contract starting in 2028. But...

Continue Reading
PNU and Cellenkos Team Up for Biotech Advancements

Updated Category News Views 13

Paving New Paths in Biotech Collaboration When a university and a biotech company shake hands to bolster their capabilities in the ever-evolving field of clinical trials and cell and gene therapies, investors and industry buffs alike should perk up. The College of Medicine at Princess Nourah bint Abdulrahman University (PNU) has just inked a Memorandum of Understanding...

Continue Reading
Tuya Gears Up for Q3 Financial Results Amid AI Growth

Updated Category News Views 11

Tuya's Third Quarter: What Are We Watching? Alright, folks, Tuya's about to drop their third quarter financial results like it's a hot potato. Circle November 23, 2026, on your calendars. That's when we'll get the goods on whether this AI cloud heavyweight is coasting or crushing it. Conference Call: The Gathering of Numbers The number-crunching brigade kickstarts at 7:30...

Continue Reading
Nevada Organic Phosphate Plans Share Consolidation

Updated Category News Views 24

The Drill Down on Nevada Organic Phosphate's Strategic Moves There's a lot to unpack here as Nevada Organic Phosphate Inc. (CSE: NOP) rolls out its big game plan. They're looking to consolidate shares, flex their financial muscles, and maybe spray some high-octane fuel on their market positioning. Could be a smart move if they pull it off, but that's a big 'if' hanging in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 386

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 584

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
NextVision's Q3 2026: Impressive Growth and Expansion

Updated Category News Views 35

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Continue Reading
Segway Powersports Ventures into Baja 1000: Ambitions Run High

Updated Category News Views 133

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Continue Reading
Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 99

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding America's Growing Net Debtor Status: Implications Ahead

Updated Category News Views 181

Shifting Dynamics of America's Net Debtor Status By Jamie McGeever Foreign investment in the U.S. has consistently outnumbered American investments abroad for several decades. This persistent imbalance has raised concerns among analysts about potential repercussions for the dollar's confidence. Despite these warnings, the anticipated crisis regarding this dynamic has not...

Continue Reading
Understanding Doximity's Short Interest Trends and Insights

Updated Category News Views 115

Diving Deeper into Doximity's Short Interest Analysis Doximity (DOCS) has attracted attention in recent financial discussions due to its short interest metrics. Recently, it was reported that the short percent of float for Doximity has decreased by 4.22%. This decline translates to approximately 5.64 million shares sold short, constituting about 4.54% of the company’s...

Continue Reading
Explore the Future of Biologics at Apogee's R&D Day

Updated Category News Views 100

Join Apogee Therapeutics' First Virtual R&D Day Apogee Therapeutics, Inc., a promising clinical-stage biotechnology firm, is poised to present its inaugural virtual Research and Development Day. Scheduled for 10:00 a.m. ET on a soon-to-come date, this event invites those interested in the transformative work happening in the field of biotechnology. Unveiling Innovations...

Continue Reading
Empowering Education: Oklahoma City School Choice Showcase

Updated Category News Views 122

Oklahoma City School Choice Showcase Set to Inspire Families Students from around Oklahoma City are gearing up for a fantastic event at Dove Science Academy, with a heartfelt message highlighting their love for their schools. The exciting gathering will showcase K–12 school choice options available in the state, aligning perfectly with the celebratory spirit of National...

Continue Reading
Experian Uncovers Identity Fraud Trends in 2024 Global Report

Updated Category News Views 661

Comprehensive Insights from the 2024 Global Identity & Fraud Report Experian has unveiled its 2024 Global Identity & Fraud Report, delivering an in-depth analysis of consumer and business responses to prevailing fraud patterns as well as effective mitigation strategies within the financial services sector. This extensive report is backed by data accumulated from over...

Continue Reading